Dynavax
![](https://www.amga.org/getmedia/b4f21785-cc3f-4277-8d8b-23b5f02d0474/membership-banner-2.webp)
Premier Corporate Partner
Company Information
2100 Powell Street, Suite 720 Emeryville, CA 94608
Contact Information
Heather Richmond
hrichmond@dynavax.com
(216) 903-9559
![LogoUrl](https://www.amga.org/getmedia/8532e614-69c0-417e-bd4c-ea602500ca38/Dynavax_logo.webp)
About
HEPLISAV-B
Hepatitis B Vaccine (Recombinant), Adjuvanted
HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.
Resources
Webinar: Liver Cancer Prevention: The Role of Adult Hepatitis B Vaccination in Disease Elimination (10/30/24)
Advertisement